Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia
Conditions
Myelofibrosis，MF
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hospital del Mar Barcelona, Barcelona, Barcelona, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Universitario Vall d´Hebron, Barcelona, Barcelona, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Clinic de Barcelona, Barcelona, Barcelona, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Universitario de Jerez, Jerez de la Frontera, Cádiz, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital General Universitario Gregorio Marañon, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Universitario Ramon y Cajal, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Fundación Jimenez Díaz, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Universitario 12 de Octubre, Madrid, Madrid, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital General Universitario Morales Meseguer, Murcia, Murcia, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Universitario de Salamanca, Salamanca, Salamanca, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Clínico Universitario Valencia, Valencia, Valencia, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital General Universitario de Valencia, Valencia, Valencia, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)Hospital Universitario Doctor Peset, Valencia, Valencia, Spain
Contact: Study coordinator (A responsible person Designated by the Sponsor) · investigacion@mfar.net · 0034934344412Contact: Principal Investigator (A Principal Investigator Designated by the Sponsor, M.D.; Ph.D.)
Study leads
Francisca Ferrer Marín, M.D.; Ph.D.
Study Chair
Fundación Jimenez Díaz